2552 studies found for:    received in the last 60 days
Show Display Options
Rank Status Study
1 Recruiting Down Syndrome Metabolic Health Study
Conditions: Down Syndrome;   Trisomy 21
Intervention:
2 Completed Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers
Condition: Healthy
Interventions: Drug: Test formulation;   Drug: Reference formulation
3 Recruiting VARITI-5 : Study of Variations of Serum ITIH5 in Women During the Genital Life and in Pathological Situations
Conditions: IVF;   Endometriosis
Intervention: Other: blood test
4 Not yet recruiting New Media Obesity Treatment in Community Health Centers
Condition: Obesity
Intervention: Behavioral: eHealth weight loss intervention
5 Recruiting A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404)
Condition: Partial Onset Seizures
Intervention: Drug: Eslicarbazepine Acetate tablets
6 Recruiting NIRS and Doppler to Predict NEC in Risk Neonates
Condition: Necrotizing Enterolitis
Intervention: Device: Cerebral and splanchnic ear infrared spectroscopy (NIRS) and mesenteric Doppler
7 Completed Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions
Condition: Fasting
Interventions: Drug: Lisinopril and Hydrochlorothiazide Tablets (20+25) mg;   Drug: Zestoretic® 20/25 lisinopril/hydrochlorothiazide Tablets
8 Not yet recruiting Suspension of Mechanical Ventilation in Ureteroscopic Lithotripsy Under General Anesthesia
Conditions: Hypercapnia;   Hypoxia
Intervention: Other: PEEP
9 Recruiting Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard Therapy
Condition: Acute Upper Gastrointestinal Hemorrhage
Intervention: Device: Endoscopic hemostasis
10 Active, not recruiting The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Behavioral: Unsupervised exercise training;   Behavioral: Supervised exercise training
11 Completed Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression
Conditions: Depressive Disorder;   Anxiety Disorders
Intervention: Behavioral: Group Behavioral Activation Therapy (GBAT)
12 Recruiting EVIDENCE: A Non-Interventional Study of Treatment and Clinical Outcomes in Chinese Patients With Gastric Cancer
Condition: Gastric Cancer
Intervention:
13 Not yet recruiting Regorafenib Post-marketing Surveillance
Condition: Colorectal Neoplasms
Intervention: Drug: BAY73-4506_Regorafenib
14 Completed To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy
Conditions: Induced Abortion;   Postaboral Pelvic Inflammatory Disease;   Sexually Transmitted Infections
Interventions: Drug: Universal antibiotic prophylaxis;   Other: Screen-and-treat
15 Not yet recruiting cSBI-M for Young Military Personnel
Conditions: Alcohol Abuse;   Tobacco Dependence;   Substance Abuse
Intervention: Behavioral: cSBI-M
16 Recruiting A Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) and Followed by Ipilimumbab Therapy in Patients With Advanced Metastatic Melanoma
Condition: Metastatic Melanoma
Interventions: Biological: Bacillus Calmette-Guérin (BCG) vaccine;   Drug: Ipilimumab
17 Recruiting Low-level Laser Therapy on Temporomandibular Disorder
Condition: Temporomandibular Disorder
Intervention: Procedure: low-level laser treatment
18 Not yet recruiting Relative Bioavailability of Oral Suspension of Rivaroxaban Compared to Standard Tablet
Condition: Biological Availability
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
19 Recruiting Preconception Reproductive Knowledge Promotion (PREKNOP)
Condition: Pregnancy
Interventions: Other: Knowing your body;   Behavioral: Healthy Lifestyle
20 Not yet recruiting 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
Conditions: High Risk MC4R Genotype;   Low Risk MC4R Genotype;   One Week or Less Antipsychotic Lifetime Exposure
Interventions: Drug: Ziprasidone;   Drug: aripiprazole, quetiapine, or risperidone

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years